glp 1 and metoprolol GLP-1 receptor agonists GLP-1 Medications for Weight Loss
Description
While GLP-1 medications have shown remarkable results for weight loss, they may also lead to some muscle loss
This can lead to gastrointestinal symptoms, malnutrition, and unintended weight loss
Prescriptions made for GLP-1 agonists under various brand names (e.g., Ozempic, Wegovy) have more than tripled since 2020
Their awareness, understanding, and confidence in a new drug can influence how quickly and widely it is adopted in clinical practice
The dynamic nature of the market, characterized by rapid advancements and potential shifts in market share, reflects the high stakes involved in addressing the global obesity epidemic
